Evidence map›Paper›PMID 34543013›Full record

ArticleACS applied materials & interfaces2021

Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation.

Dipika Nandi, Manisha Shivrayan, Jingjing Gao, Jithu Krishna, Ritam Das, Bin Liu, S Thayumanavan, Ashish Kulkarni

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Caspase-1 Responsive Nanoreporter forACS applied materials & interfaces · 2023
    Article
  8. Article
  9. Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  10. Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dipika NandiDepartment of Chemical Engineering, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Manisha ShivrayanDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Jingjing GaoDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Jithu KrishnaDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Ritam DasDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
Bin LiuDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.
S ThayumanavanDepartment of Chemistry, University of Massachusetts, Amherst, Massachusetts 01003, United States.ORCID https://orcid.org/0000-0002-6475-6726
Ashish KulkarniDepartment of Chemical Engineering, University of Massachusetts, Amherst, Massachusetts 01003, United States.ORCID https://orcid.org/0000-0002-5713-2202

Funding

Biotechnology Training Program in Applied Life SciencesT32GM135096 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Jeanne Ann Hardy, Ashish A. Kulkarni · 2020 to 2026
$3.9M
Protein-Induced Self-Assembly and Disassembly of Nanostructures Based on OligoR35GM136395 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI Sankaran Thayumanavan · 2020 to 2026
$3.5M
NIGMS NIH HHS R35 GM136395NIGMS NIH HHS T32 GM135096
6 · The paper itself

Abstract

Designer nanomaterials capable of delivering immunomodulators to specific immune cells have been extensively studied. However, emerging evidence suggests that several of these nanomaterials can nonspecifically activate NLRP3 inflammasomes, an intracellular multiprotein complex controlling various immune cell functions, leading to undesirable effects. To understand what nanoparticle attributes activate inflammasomes, we designed a multiparametric polymer supramolecular nanoparticle system to modulate various surface and core nanoparticle-associated molecular patterns (NAMPs), one at a time. We also investigated several underlying signaling pathways, including lysosomal rupture-cathepsin B maturation and calcium flux-mitochondrial ROS production, to gain mechanistic insights into NAMPs-mediated inflammasome activation. Here, we report that out of the four NAMPs tested, core hydrophobicity strongly activates and positively correlates with the NLRP3 assembly compared to surface charge, core rigidity, and surface hydrophobicity. Moreover, we demonstrate different signaling inclinations and kinetics followed by differential core hydrophobicity patterns with the most hydrophobic ones exhibiting both lysosomal rupture and calcium influx early on. Altogether, this study will help design the next generation of polymeric nanomaterials for specific regulation of inflammasome activation, aiding efficient immunotherapy and vaccine delivery.

Indexed as

AnimalsCalciumCoumarinsHydrophobic and Hydrophilic InteractionsInflammasomesLysosomesMacrophagesMiceMitochondriaNanoparticlesNLR Family, Pyrin Domain-Containing 3 ProteinPolyethylene GlycolsReactive Oxygen SpeciesCalciumCoumarinsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinPolyethylene GlycolsReactive Oxygen Speciesactivationhydrophobicityinflammasomepolymer nanoparticlessupramolecular nanoparticles

Identifiers

PMID34543013
PMCPMC8761361

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.